1. Na+,K+-ATPase is the membrane enzyme catalysing the active transport of Na+ and K+ across the plasma membrane of animal cells. A reduced activity of Na+,K+-ATPase has been described in gestational hypertension in a variety of cell types, in agreement with the hypothesis that gestational hypertension can induce membrane transport modifications similar to those reported for essential hypertension. The causes of the reduced Na+,K+-ATPase activity are still debated. 2. The aim of the present work was to investigate the molecular mechanism of the reduced enzymic activity in gestational hypertension using as a model Na+,K+-ATPase purified from human placenta. Na+,K+-ATPase obtained from term placentas of eight healthy pregnant women and eight age-matched women with gestational hypertension was purified as previously described. 3. We observed in gestational hypertension: (i) a significant increase in the activation energies above transition temperature; (ii) a significant decrease in the fluorescence polarization of 1-(44rimethylami-nopheny1)-6-phenyl-l,3,5hexatriene (i.e. increased fluidity) and an increase in the mean lifetime (modified hydrophobicity); (iii) a lower K,, suggesting an enzymic structural modification; and (iv) an increased mean lifetime and rotational relaxation time of pyrene isothiocyanate, indicating a modified ATP binding site.
INTRODUCTION
Na+,K+-ATPase is a tetramer composed of two chains of molecular weight 110kDa and two chains of molecular weight 45kDa. The complex is an integral membrane protein with an enzymic activity requiring the presence of phospholipids, which indicates a strict relation with the membrane physicochemical structure [l]. The ATP binding site is located at the cytoplasmic site of the rx-subunit and is a large loop between the fourth and fifth transmembrane segments (the H4-Hs loop).
A reduction in Na+,K+-ATPase activity has been described during essential hypertension [2] and gestational hypertension (GH) [3] . Such observations support the hypothesis that in GH the same modifications in the transmembrane cation transport as in essential hypertension might occur [4] . The availability of an enzyme model derived from human tissue (i.e. Na+,K+-ATPase purified from placenta), made it possible to investigate further the mechanisms of inhibition during GH. An increased number of molecules responsible for active sodium transport was present in the placental microsomal fraction from women with GH, indicating that the generally reduced Na+,K+-ATPase activity was due to a decreased and/or abnormal enzyme function of the Na+,K+-ATPase molecule [4, 
51.
Moreover, a significant modification of the ouabain binding site was found, with increased ouabain affinity during GH, which might cause a greater inhibitory response of the molecule to circulating endogenous digoxin-like substances [6-91.
In order to study the role of the lipid environment in the modification of Na+,K+-ATPase function during GH, we investigated the transition temperature and activation energy of the enzyme purified from human placenta and the fluidity of the lipid annulus by steady-state and dynamic fluorescence using the probe 1-(4-trimethylarninophenyl)-6-phenyl-173,5-hexatriene (TMA-DPH). An indirect index of conformational modification of the protein's secondary and tertiary structure was also studied through the investigation of the accessibility of tryptophan residues by tryptophan fluorescence quenching. In the present work a pyrene derivative of isothiocyanate that has been shown to bind to the ATP binding site at Lys-480 and/or at Lys-501 [lo, 111 was used to investigate if the ATP binding site is modified during GH.
MATERIALS AND METHODS

Enzyme purification
Placentas were obtained within 15 min after delivery from eight healthy pregnant women (aged 29 +5 years) and eight women affected by GH (aged 27 +4 years). Gestational age at delivery was similar in the two groups (control women, 39 k 1 weeks; GH patients, 38.3 f 1.7 weeks). The criterion for diagnosing GH was the presence of diastolic blood pressure of 90mmHg or greater on at least two consecutive occasions in previously normotensive women without proteinuria. Mean blood pressure was 71.8mmHg in the normotensive group and 99.8mmHg in the hypertensive women. All the subjects studied showed normal fetal intrauterine growth evaluated by ultrasound examinations performed near term and the weight of their babies was between 3 and 3.6kg. Parity and methods of delivery were not different between the two groups. None of the women in the GH group had received antihypertensive medication before delivery. Patients gave informed consent to the study.
The Na+,K+-ATPase was purified from trophoblastic placental tissue according to a modification of Jorgensen's method [12] , as previously described [13] . Connective tissue and large vessels were dissected from the trophoblast with a scalpel.
The final preparation consisted of complete membrane fragments, including phospholipids and cholesterol, and showed two major bands (96 and 57 kDa) on SDS gel electrophoresis corresponding to the two subunits of the Na+,K+-ATPase. Protein concentration was determined by Lowry's method using BSA as standard. The Na+,K+-ATPase activity was measured according to Esman [14] at 37°C. Briefly, 0.5 g of the isolated enzyme was added to a medium containing 130 mmol/l sodium chloride, 20 mmolll potassium chloride, 4 mmol/l magnesium chloride and 3mmolll ATP in the presence or absence of 1 mmol/l ouabain. The detection of inorganic phosphate (Pi) was performed by the method of Esman [14] .
The protein purity of the enzyme preparation estimated from the content of a-and P-peptide on Coomassie Blue-stained SDS gel was about 90%. The specific enzyme activity was about 1100 mol Pi h-' mg-' protein (ninefold higher than in crude membranes).
In order to measure the temperature dependence of the enzyme, determinations of the specific activity of the purified enzyme preparations were performed at various temperatures (4, 10, 21, 30, 37, 45 and 55°C) by the method of Esman [14] . The activation energies were calculated according to the Arrhenius equation, after plotting log v versus 1/T [l5].
Fluidity studies
The fluorescent probe TMA-DPH was incubated with the purified enzyme at 37°C for 5 min following the procedures described by Shinitzky and Barenholz [16] . The probe concentration was chosen such that the final probe/phospholipid ratio was always less than 1:lOOO. After labelling, the steadystate fluorescence measurements were carried out on a Perkin-Elmer MPF 66 spectrofluorimeter equipped with fluorescence polarization accessory and a controlled temperature cell holder. The excitation and emission wavelengths were 360 and 430 nm respectively. The fluorescence polarization value (P) was obtained from the fluorescence intensities parallel (Ill) and perpendicular (ZI) to the polarization direction of excitation light using the equation of Schachter and Shinitsky [17] . P indicates the freedom of rotation of the fluorescent probe; a decrease in the value of P indicates a higher mobility of the probe TMA-DPH in the lipid microenvironment in which the probe is localized (i.e. increased fluidity). To obtain further information on the microenvironment in which the probe is embedded, dynamic fluorescence measurements were performed on the labelled enzyme using an ISS K2 multifrequency cross-correlation phase and modulation fluorimeter (ISS Inc., Urbana, Champaign, IL, U.S.A.). Phase and modulation measurements were made in the range 5-200 MHz with a xenon lamp and monochromator as a source of excitation light. Fluorescence emissions from the samples were observed through appropriate Schott filters. The temperature of the samples was maintained at 25°C. The average lifetime value (z) was calculated from the best fit of measured data as described by Lakowicz et al. [18] .
Tryptophan fluorescence quenching
The tryptophan fluorescence quenching data were obtained by adding increasing concentrations of an 8 moll1 solution of acrylamide to the purified enzyme diluted in 40mmol/l Tris-HC1 pH7.4 (protein concentration 90 ,ug/ml). Data were corrected for acrylamide absorbance [ 191. Fluorescence was recorded on a Perkin-Elmer MPF66 spectrofluorimeter at an excitation wavelength of 295 nm and intensity was corrected for dilution. The experiments were performed on purified protein in the presence of 2 mmol/l magnesium chloride. The absence of Na+ and K+ from the medium hampered the transition from the E l to the E2 conformation during the experiments.
Anisotropy decay studies of the fluorescent probe pyrene isothiocyanate (PylTC)
PyITC was dissolved in dimethylformamide and subsequently in buffer (50 mmol/l Tris-HC1, 3 mmolfl magnesium chloride, pH 7.4). The enzyme (1 mg/ml) was labelled with 8 mmol/l PyITC and then centrifuged three times at lOOOOOOg to remove the unreacted probe.
A frequency domain approach was used as previously described for the TMA-DPH studies. The rotational relaxation time ( p ) was also measured as previously reported [18] .
Statistical analysis
Statistical evaluation was made by paired Student's t-test. Means were considered significantly different when P-values were <0.05.
RESULTS
The study of the temperature dependence of the enzyme (Table 1) revealed that the transition temperature was the same for normal enzyme as for the GH enzyme (21"C), whereas the activation energies were significantly higher, above transition temperature (Table 1 , P<O.Ol).
The fluorescence polarization (P) of TMA-DPH, at 37"C, was significantly decreased in the enzyme purified from women with GH compared with that from healthy women ( Table 2 ; P < 0.01), indicating a higher fluidity of the lipid microenvironment of the isolated Na+,K+-ATPase. Significant changes were observed at the same temperature by the dynamic fluorescence study of the average lifetime value of TMA-DPH (Table 2, [20] , Kq (Stern-Volmer constant) and Fa (fractional maximum accessible protein fluorescence) were calculated for the enzyme from normal and hypertensive subjects. Briefly, it was assumed that all tryptophan residues present in the protein are independent, equally absorbing, fluorophores under conditions of validity of the SternVolmer law for each fluorophore [21] . Moreover, it was assumed that all tryptophan residues buried in the hydrophobic part of the enzyme preparation are totally inaccessible to acrylamide, and that the accessibility of tryptophan is described by the same Stern-Volmer constant, K,. The data obtained indicated that the Na+,K+-ATPase purified from women with GH had a different Stern-Volmer constant (K, = 1.80f0.13 compared with 2.48 f0.16 in control subjects) and similar exposition of tryptophan residues to acrylamide (GH, Fa = 1.00f0.05; control, Fa = 1.08 f 0.04).
As for the QITC results, increased z and p were observed in Na+,K+-ATPase obtained from GH patients (Table 3 ; P < O . O l and P<O.OOl respectively).
DISCUSSION
The pathogenic mechanisms leading to the development of GH have been assumed to involve an increased cytoplasmic sodium and calcium concentration in the vascular wall muscle cells due to a reduced Na+,K+-ATPase activity [22] . In turn, the decreased sodium pump activity has been ascribed to a circulating inhibitor [23] or to an intrinsic abnormality of the protein molecule [24] .
The absence of an enzymic model derived from human tissue made it difficult to study the mechanisms of inhibition of Na+,K+-ATPase activity during GH. The availability of purified enzyme from human placenta allowed a more accurate and reliable investigation of the molecular alterations occurring during GH.
It is well known that ATPases are sensitive to changes in physical parameters relating to membrane fluidity and that Na+,K+-ATPase activity is affected by small modifications in the motional properties of surrounding lipids [25] . In the present work we observed a change in Na+,K+-ATPase activation energy that might result from subconformational changes in the protein depending on its Previous studies by our group have demonstrated a significant modification in the lipid composition of the syncytiotrophoblast plasma membranes during GH, with increased cholesterol/phospholipid ratio and unsaturated/saturated fatty acids ratio [27] . It might therefore be hypothesized that the lipid annulus of the enzyme is also modified during GH, reflecting the general alteration of the trophoblast membrane. Such a modification might affect the activity and activation energies of the Na+,K+-ATPase, as previously reported for mitochondria1 ATPase [25] .
A possible subconformational change in the protein is also suggested by the data on tryptophan fluorescence quenching, indicating that in placentas from women with GH, Na+,K+-ATPase might have a different arrangement within the lipid annulus. The lower Kq value suggests a decreased degree of accessibility of tryptophan residues to acrylamide quenching. Modifications in the primary protein structure of Na+,K+-ATPase during GH cannot be excluded on the basis of the present work, although this putative primary modification should be able to affect the whole arrangement of the protein within the lipid annulus, from the ATP binding site to the ouabain binding site [5, 61. On the contrary, the present data seem to be consistent with a remodelling role of lipids on the Na+,K+-ATPase during GH, as the alterations observed in the protein might be explained by a modification in the lipid-enzyme interaction. Further studies on the structure of the protein are in progress in order to clarify the role of the lipid-enzyme complex in the pathophysiology of GH.
